AstraZeneca-Oxford coronavirus vaccine trials resume
Last week, we covered news that AstraZeneca and Oxford University had to pause late-stage trials of their coronavirus vaccine, due to a volunteer falling ill.
Now, with the cause of the illness investigated, the vaccine has been determined safe and the trials can start again.
This is far from the only coronavirus vaccine in development, of course, but any possible solution we might have to the ending the pandemic is important and a source of hope.
Read on to learn more about how the AstraZeneca-Oxford coronavirus vaccine was allowed to resume testing.
Contact Our Writer – Alysa Salzberg